Valuation ·
Why valuation methods disagree
A weighted average can hide the most useful part of a valuation: why the methods disagree in the first place.
The Lennox report combined DCF, two peer-multiple approaches and a dividend model. Its reported estimates ranged from $101.59 to $634.51 per share. That spread is more informative than the blended $523.81 on its own.
Start with what each method measures
The DCF values forecast cash available to the firm, then bridges enterprise value to equity. In the report, terminal value contributes roughly three-quarters of enterprise value. Small changes in the long-run assumptions can therefore move the answer substantially.
Multiples ask how the market prices comparable earnings or operating profit. The reported EV/EBITDA and P/E estimates were $634.51 and $631.12. Their agreement does not make peer selection, business mix or the measurement period irrelevant.
The dividend model produced $101.59 under its specified payout path. A low current payout and the role of share repurchases help explain why that path captures a different picture of distributions. The result alone does not establish that the shares are overvalued.
Reconcile before combining
There is also a source issue to resolve. For 2025, the report lists NOPAT of $845m, depreciation of $97m, capital expenditure of $180m and a $75m working-capital outflow. Under its stated FCFF formula, those inputs give $687m; the table shows $1,047m. That difference needs reconciliation before the DCF or blended target can be treated as verified.
My takeaway is a sequence: reconcile the cash flows, align the dates and capital structure, then examine what each method assumes. Weighting the outputs is a later judgment. It cannot repair an inconsistent input table or make a weak comparison stronger.
Source and scope. This reflection uses the March 2026 group report’s reported estimates, not a new valuation. See PDF page 7 for the cash-flow table and pages 9–11 for the valuation methods. The original PDF is preserved; the cash-flow discrepancy remains a review item.